Given that ETS-FLI transcriptional activity can be regulated by LSD1 in other cancers, our results similarly demonstrated that LSD1 inhibition could repress FLI target genes related to angiogenesis and migration, thereby promoting cancer progression or higher histological grading [21]. Here, FLII is linked to cancer.